When you prescribe high risk drug Sodium Valproate to females, there must be a warning to ensure contraception is provided in view of the significant risks of birth defects and developmental disorders that could occur in children through its use during pregnancy. This applies to females of childbearing age.
Latest News
Clinical Safety issue where a KIS Special Note recorded for patients registered at Vision GP practices may not be the most recent version of that data
Issue with prescribing generic drugs that are parallel import items using Vision.
Advisory post highlighting the potential for divergence between drug-drug interaction warning severity levels assigned by Cegedim Healthcare Solutions and those included in the BNF and Stockley’s information for interactions.
** RESOLVED ** Vision Consultation Manager Crashing on Failed Bulk Reauthorisation of Repeat Master Prescriptions
Tags: Clinical Safety,Vision 3
** RESOLVED ** Vision Consultation Manager crashing on failed bulk reauthorisation of repeat master prescriptions
** UPDATE - Warning Solution Implementation Assigned to DLM 850 ** Clinical Safety Issue – Age Related Prescribing Precautions not Showing when Prescribing to Neonates
Tags: Clinical Safety,Vision 3
Advisory post regarding issue relating to age-related prescribing precautions not displaying in Vision when prescribing to neonatal patients under 1 month of age (i.e. 0-28 days old).
When you add a medication, Vision 3 automatically runs specific drug checks depending on your set up. It is important for patient safety that Drug Checks are set up effectively. The Benefits of Automatic Drug Checks guide details the available checks and how to set them up within Vision 3.
Inappropriate Anti-coagulation of Patients with a Mechanical Heart Valve
Tags: Clinical Safety,Vision
Blog post on National Patient Safety Alert that has been issued on the risk of inappropriate anticoagulation of patients with a mechanical heart valve.
Advisory information on where a patient's previous acute for Methotrexate is copied and turned into a repeat master and dosage is entered as free text.
Advisory information regarding allocation of 'Usual GP' to an individual GP when (re)registering a patient in line with pooled list arrangements in Wales